investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Development of antibody-based cancer therapies

Mitchell Ho

1 Collaborator(s)

Funding source

National Cancer Institute (NIH)
To identify and validate new targets in hepatocellular carcinoma for antibody-based liver cancer therapy

Related projects

Xin Wei Wang

Molecular signatures for liver cancer diagnosis and treatment stratification

Liver and intrahepatic bile ducts

Pathology

Xin Wei Wang

The role of cancer stem cells in Liver cancer heterogeneity and subtypes

Liver and intrahepatic bile ducts

Pathology

John Tavis

Alpha Hydroxytropolones as HCC Preventatives

Liver and intrahepatic bile ducts

Pathology

Snorri Thorgeirsson

Genomic Classification of Human Liver Cancer

Liver and intrahepatic bile ducts

Pathology

Gregory F Oxenkrug

Depression, insulin resistance and xanthurenic acid in hepatitis C virus patients

Liver and intrahepatic bile ducts

Pathology

Xin Wei Wang

The Role of Cancer Stem Cells in Liver Cancer Heterogeneity and Subtypes – Rockville

Liver and intrahepatic bile ducts

Pathology

Ningling Kang

Hepatic Stellate Cell Regulation of Metastatic Growth in the Liver

Liver and intrahepatic bile ducts

Pathology

Tim Greten

Immune Suppressor Mechanism in a Murine Model of Hepatitis and Liver Cancer

Liver and intrahepatic bile ducts

Pathology

John Tavis

HBV Drug Development

Liver and intrahepatic bile ducts

Pathology